G V Doern
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pneumonia and Respiratory Infections 6
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- Angela B. Brueggemann (3 shared papers)D. J. Hoban (1 shared paper)M. Roussel‐Delvallez (1 shared paper)Ronald N. Jones (1 shared paper)H. Preston Holley (1 shared paper)Gary L. Pierce (1 shared paper)Alan Rauch (1 shared paper)Kari C. Kugler (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Clinical Infectious Diseases (3 papers)Journal of Clinical Microbiology (2 papers)Diagnostic Microbiology and Infectious Disease (1 paper)Drugs (1 paper)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
G V Doern
12 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 294
- Applied Microbiology and Biotechnology 73
- Microbiology 229
- Epidemiology 713
- Pharmacology 305
Countries citing papers authored by G V Doern
This map shows the geographic impact of G V Doern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G V Doern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G V Doern more than expected).
Fields of papers citing papers by G V Doern
This network shows the impact of papers produced by G V Doern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G V Doern. The network helps show where G V Doern may publish in the future.
Co-authors
The 19 scholars most cited alongside G V Doern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 322 | |
| 2 | 1997 | 257 | |
| 3 | 2005 | 111 | |
| 4 | 1997 | 91 | |
| 5 | 2004 | 60 | |
| 6 | 1996 | 48 | |
| 7 | 1998 | 48 | |
| 8 | 1986 | 47 | |
| 9 | 1981 | 44 | |
| 10 | 1988 | 36 | |
| 11 | 1996 | 26 | |
| 12 | 1999 | 1 |
About G V Doern
G V Doern is a scholar working on Epidemiology, Pharmacology, Microbiology, Molecular Biology and Infectious Diseases, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Bacterial Infections and Vaccines (3 papers), Antibiotic Resistance in Bacteria (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Traditional and Medicinal Uses of Annonaceae (1 paper), Streptococcal Infections and Treatments (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Molecular Medicine (294 citations), Applied Microbiology and Biotechnology (73 citations), Microbiology (229 citations), Epidemiology (713 citations) and Pharmacology (305 citations). G V Doern has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Angela B. Brueggemann, D. J. Hoban, M. Roussel‐Delvallez, Ronald N. Jones, H. Preston Holley, Gary L. Pierce, Alan Rauch, Kari C. Kugler, Kristopher P. Heilmann and C. Rice. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.